During angiogenesis, ECT2 controls VEGF-induced activation of Rho-GTPases. Knockdown of ECT2 inhibits sprouting angiogenesis. During tumorigenesis, deregulated ECT2 drives tumor cell proliferation. This evidence concerns the gene ECT2 and neoplasm.